Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Plos One|May 2, 2020
"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and SpainWendy Davis, Andrea Mantsios, Tahilin Karver, et al.
Behavioural Brain Research|January 18, 2011
Neural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI studyJoseph Goveas, Chunming Xie, Zhilin Wu, et al.
AIDS Research and Treatment|July 30, 2020
Real-World Experience with Dolutegravir-Based Two-Drug RegimensDouglas Ward, Moti Ramgopal, David J Riedel, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 7, 2014
Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriersWenjun Li, Piero G Antuono, Chunming Xie, et al.
Journal of the Neurological Sciences|January 7, 2014
Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructureWenjun Li, L Tugan Muftuler, Gang Chen, et al.
Open Forum Infectious Diseases|May 27, 2020
The HIV Outpatient Study-25 Years of HIV Patient Care and Epidemiologic ResearchKate Buchacz, Carl Armon, Frank J Palella, et al.
Neuroimage|April 15, 2008
Modeling of region-specific fMRI BOLD neurovascular response functions in rat brain reveals residual differences that correlate with the differences in regional evoked potentialsChristopher P Pawela, Anthony G Hudetz, B Douglas Ward, et al.
Plos One|March 4, 2014
HIV-1 transmission patterns in antiretroviral therapy-naïve, HIV-infected North Americans based on phylogenetic analysis by population level and ultra-deep DNA sequencingLisa L Ross, Joseph Horton, Samiul Hasan, et al.
HIV Clinical Trials|July 11, 2017
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTIAnton Pozniak, Jason Flamm, Andrea Antinori, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2020
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency VirusPaul E Sax, Jürgen K Rockstroh, Anne F Luetkemeyer, et al.
Pageof 9